Enzyme-Linked Immunosorbent Assay (ELISA) Market Size & Share, By Type Of Elisa Kits, Technology, Application - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 3190| Published Date: Jan-2025| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Enzyme-Linked Immunosorbent Assay (ELISA) Market size is expected to expand from USD 105.84 billion in 2024 to USD 187.76 billion by 2034, demonstrating a CAGR of more than 5.9% between 2025 and 2034. In 2025, the industry revenue is estimated to reach USD 111.46 billion.

Base Year Value (2024)
USD 105.84 billion
CAGR (2025-2034)
5.9%
Forecast Year Value (2034)
USD 187.76 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Enzyme-Linked Immunosorbent Assay Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Market Dynamics

Market Growth Drivers and Industry Trends

Growth Drivers & Opportunity: 1. Increasing prevalence of infectious diseases: The rising incidence of infectious diseases such as HIV, hepatitis, and Lyme disease is driving the demand for ELISA testing. ELISA is a widely used diagnostic tool for detecting and monitoring infectious diseases, and as the global burden of these diseases continues to grow, the demand for ELISA testing is expected to increase. 2. Growing application in drug development and research: ELISA is an essential tool in drug development and research, as it is used for screening potential drug candidates, determining drug efficacy, and monitoring biomarker levels. With the increasing focus on personalized medicine and precision therapeutics, the demand for ELISA testing in drug development and research is expected to rise. 3. Technological advancements in ELISA testing: Ongoing advancements in ELISA technology, such as the development of automated systems, improved detection methods, and enhanced sensitivity, are expanding the capabilities of ELISA testing. These technological advancements are increasing the accuracy and efficiency of ELISA testing, making it a more attractive option for diagnostic and research applications. 4. Growing demand for point-of-care testing: The increasing demand for rapid and decentralized diagnostic testing is driving the adoption of point-of-care ELISA testing. Point-of-care ELISA tests offer the advantages of rapid results, minimal sample preparation, and ease of use, making them well-suited for applications in resource-limited settings, physician offices, and emergency care facilities. Industry Restraints: 1. High cost of ELISA testing: The cost of ELISA testing, including equipment, reagents, and consumables, can be a significant barrier to adoption, particularly in resource-constrained healthcare settings. The high cost of ELISA testing may limit its use in certain markets and impede its widespread adoption. 2. Limited sensitivity and specificity: While ELISA testing is a widely used and well-established diagnostic tool, it can have limitations in terms of sensitivity and specificity, particularly for certain biomarkers and analytes. These limitations can impact the accuracy and reliability of ELISA test results, leading to potential challenges in clinical decision-making and research applications. 3. Competition from alternative technologies: The ELISA market faces competition from alternative diagnostic technologies, such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray-based assays. These alternative technologies offer advantages such as higher sensitivity, multiplex testing capabilities, and faster turnaround times, posing a challenge to the growth of the ELISA market.

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Enzyme-Linked Immunosorbent Assay Market
Largest Region
North America
XX% Market Share by 2034
North America: The Enzyme-Linked Immunosorbent Assay (ELISA) market in North America, particularly in the United States and Canada, is expected to experience significant growth in the forecast period. This can be attributed to the increasing prevalence of chronic diseases, growing adoption of advanced diagnostic technologies, and a well-established healthcare infrastructure in the region. Additionally, the presence of key players and substantial investments in research and development activities further contribute to the market growth in North America. Asia Pacific: In Asia Pacific, specifically in countries such as China, Japan, and South Korea, the ELISA market is poised for substantial growth. Factors driving this growth include the rising geriatric population, increasing healthcare expenditure, and advancements in healthcare infrastructure. Additionally, the growing prevalence of infectious diseases and the focus on early disease detection are expected to drive the demand for ELISA diagnostic tests in the region. The presence of a large population base also presents significant opportunities for market growth in Asia Pacific. Europe: The ELISA market in Europe, particularly in countries like the United Kingdom, Germany, and France, is expected to witness steady growth. The region boasts a well-established healthcare system, high healthcare expenditure, and a strong focus on research and development activities. These factors, coupled with the increasing prevalence of chronic and infectious diseases, are expected to drive the demand for ELISA diagnostic tests in Europe. Furthermore, the presence of key market players and technological advancements in the region further support market growth.
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Segment Analysis of Enzyme-Linked Immunosorbent Assay (ELISA) Market Type of ELISA Kits The type of ELISA kits segment in the market refers to the different variations and formats of ELISA kits available. This includes direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA kits. Direct ELISA kits are designed to detect the presence of an antigen in a sample, while indirect ELISA kits are used to detect the presence of antibodies. Sandwich ELISA kits are commonly used for quantitative detection of antigens, and competitive ELISA kits are used for the detection of small molecules. The variety of available ELISA kits allows researchers and clinicians to choose the most suitable format for their specific testing needs. Technology The technology segment of the ELISA market includes the different methods and platforms used in ELISA testing. This encompasses traditional ELISA, chemiluminescent ELISA, fluorescence ELISA, and colorimetric ELISA. Traditional ELISA involves the use of enzyme-substrate reaction to produce a visible signal, while chemiluminescent ELISA and fluorescence ELISA utilize light emission to detect the presence of the target antigen or antibody. Colorimetric ELISA, on the other hand, relies on color changes to indicate the presence of the analyte. The availability of various technologies provides flexibility and options for researchers and clinicians to choose the most suitable method for their specific testing requirements. Application The application segment of the ELISA market covers the various areas where ELISA testing is utilized. This includes diagnostic testing, drug development and monitoring, food safety testing, and environmental monitoring. ELISA is widely employed in clinical laboratories for diagnosing infectious diseases, autoimmune disorders, and allergies. In drug development, ELISA is used for quantifying biomarkers and monitoring the immune response. Additionally, ELISA has applications in food safety testing to detect contaminants and allergens, as well as in environmental monitoring for detecting pollutants. The diverse applications of ELISA demonstrate its versatility and significance across different industries and sectors.
Segment Sub-Segment Largest Segment Fastest Growing
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

The Enzyme-Linked Immunosorbent Assay (ELISA) market is highly competitive, with several key players competing for market share. The market is characterized by intense competition, rapid technological advancements, and new product developments. Major players in the market are focusing on strategies such as mergers and acquisitions, partnerships, and product launches to maintain their competitive position. The market is also witnessing the entry of new players, which is further intensifying the competition. The competitive landscape is also influenced by factors such as pricing, product quality, after-sales service, and brand image. Top Market Players: 1. Thermo Fisher Scientific, Inc. 2. Bio-Rad Laboratories, Inc. 3. Siemens Healthineers 4. Merck KGaA 5. BD (Becton, Dickinson and Company) 6. PerkinElmer, Inc. 7. Abcam plc 8. Agilent Technologies, Inc. 9. Bio-Techne Corporation 10. BioMérieux SA
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Enzyme-Linked Immunosorbent Assay Market — Custom Segments

Segment Sub-Segment
No segment data available.

Enzyme-Linked Immunosorbent Assay Market — Custom TOC

Custom Chapter Chapter Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →